Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ALZN | US
-0.02
-1.20%
Healthcare
Biotechnology
31/07/2024
17/10/2024
1.64
1.65
1.68
1.51
Alzamend Neuro Inc. an early clinical-stage biopharmaceutical company focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial which delivers a therapeutic combination of lithium proline and salicylate for the treatment of Alzheimer's bi-polar disorder post-traumatic stress disorder major depressive disorder other neurodegenerative diseases and psychiatric disorders; and AL002 that completed preclinical stage which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro Inc. was incorporated in 2016 and is headquartered in Atlanta Georgia.
View LessLow Market Beta (-0.4 to 0.8)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
43.9%1 month
62.2%3 months
390.2%6 months
1172.6%-
-
7.23
-
-
-3.13
-
-
-7.32M
7.34M
7.34M
-
-
-
-
-4.41K
0.27
2.80
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.43
Range1M
0.50
Range3M
13.66
Rel. volume
0.88
Price X volume
535.22K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pulmatrix Inc | PULM | Biotechnology | 2.03 | 7.41M | -4.70% | n/a | 0.18% |
TFFP | TFFP | Biotechnology | 2.06 | 7.14M | -1.44% | n/a | 1.26% |
Portage Biotech Inc | PRTG | Biotechnology | 6.71 | 7.04M | 0.15% | 0.27 | 1.47% |
Moleculin Biotech Inc | MBRX | Biotechnology | 2.36 | 6.71M | -2.48% | n/a | 3.00% |
Purple Biotech Ltd | PPBT | Biotechnology | 4.18 | 6.55M | 1.95% | n/a | 0.89% |
Aptose Biosciences Inc | APTO | Biotechnology | 0.36 | 6.52M | -2.17% | n/a | -37.59% |
CDIO | CDIO | Biotechnology | 0.2113 | 6.47M | -7.49% | n/a | 28.31% |
Adial Pharmaceuticals Inc | ADIL | Biotechnology | 0.9701 | 6.21M | -5.82% | n/a | 0.00% |
Hoth Therapeutics Inc | HOTH | Biotechnology | 0.9 | 6.21M | -3.26% | n/a | 0.44% |
Molecular Templates Inc | MTEM | Biotechnology | 0.93 | 6.16M | 186.07% | n/a | 155.07% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -3.13 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 7.23 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 390.18 | 72.92 | Riskier |
Debt to Equity | - | -1.24 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 7.34M | 3.78B | Emerging |